Metastatic Rhabdomyosarcoma
Also known as: Metastatic rhabdomyosarcoma (morphologic abnormality) / Metastatic rhabdomyosarcoma (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01030 | Topotecan | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB01030 | Topotecan | DNA topoisomerase I, mitochondrial | target |
| DB01030 | Topotecan | DNA topoisomerase 1 | target |
| DB01030 | Topotecan | ATP-binding cassette sub-family G member 2 | transporter |
| DB01030 | Topotecan | P-glycoprotein 1 | transporter |
| DB01030 | Topotecan | DNA | target |
| DB01030 | Topotecan | Multidrug and toxin extrusion protein 1 | transporter |
| DB01030 | Topotecan | Multidrug and toxin extrusion protein 2 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00531 | Cyclophosphamide | 3 | Recruiting | 1 |
| DB00970 | Dactinomycin | 3 | Recruiting | 1 |
| DB14546 | Sulfate ion | 3 | Recruiting | 1 |
| DB00541 | Vincristine | 3 | Recruiting | 1 |
| DB00361 | Vinorelbine | 3 | Recruiting | 1 |